News
AstraZeneca in billion-dollar deal in AI
AstraZeneca has signed a strategic research collaboration with Chinese pharmaceutical company CSPC Pharmaceuticals Group Limited, based in Shijiazhuang. The collaboration focuses...
Kancera rises on positive results from the KANDOVA study
Kancera has published positive overall results from the KANDOVA study...
New success strengthens Alzinova's licensing opportunities for ALZ-101
Alzinova has presented new data that strengthens the...
The largest funders and investors in Scandinavian life science
Scandinavian life science shines brightly on the global...
RFK Jr. appoints new members to vaccine committee
On Tuesday, US Secretary of Health and Human Services Robert F. Kennedy dismissed...
BioInvent focuses on first-line treatment
BioInvent's Phase I dose escalation study of BI-1206, in combination with...
Deep Apple and Novo Nordisk in collaboration on oral drugs
Deep Apple Therapeutics has entered into a research and...
Nvidia and Novo Nordisk collaborate in drug discovery
Nvidia has entered into a collaboration with Novo Nordisk...
Demant acquires KIND for DKK 5,2 billion
The Danish medical technology group Demant has signed an agreement to...
DNB // Back Bay takes the pulse of the life science market
In the report "Vital Signs: A Pulse Check on...
Jakob Just-Bomholt new CEO of Elekta
Elekta's Board of Directors has appointed Jakob Just-Bomholt as new...
HIV research takes a step forward with mRNA breakthrough
Australian researchers have made significant progress in...
Notes
Alligator Bioscience receives FDA approval for phase III mitazalimab dose
Lena Åredal appointed new CEO of SyntheticMR
BioArctic advances phase IIa study with exidavnemab
Novo Nordisk advances amycretin to Phase III
BioNTech acquires CureVac for $1,25 billion
NEWSLETTER
NEWS
AstraZeneca in billion-dollar deal in AI
Kancera rises on positive results from the KANDOVA study
New success strengthens Alzinova's licensing opportunities for ALZ-101
Upcoming events!
Investing in Life Science
We cover early-stage, growth-stage and late-stage investments. From business angels and seed investors driving medical breakthroughs, to investments empowering promising...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
Bispecific and Chinese the new black in cancer
The venture capital cycle is complete – we are back where we started
